Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore.

The India Fund, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

PHILADELPHIA, PA / ACCESS NEWSWIRE / MAY 9, 2025 / THE FOLLOWING ABRDN U.S. CLOSED-END FUNDS (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW)(NYSE AMERICAN:FAX, FCO, IAF, VFL), ANNOUNCED TODAY THAT THE CLOSED END FUNDS IN THE CHART DIRECTLY BELOW WILL PAY THE DISTRIBUTIONS INDICATED ON A PER SHARE BASIS ON MAY 30, 2025 TO ALL SHAREHOLDERS OF RECORD AS OF MAY 22, 2025 (EX-DIVIDEND DATE MAY 22, 2025). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF THE ABRDN HEALTHCARE INVESTORS (HQH), THE ABRDN LIFE SCIENCES INVESTORS (HQL), THE ABRDN AUSTRALIA EQUITY FUND, INC. (IAF) AND THE INDIA FUND, INC. (IFN) WHICH WILL PAY ON JUNE 30, 2025, TO ALL SHAREHOLDERS OF RECORD AS OF MAY 22, 2025 (EX-DIVIDEND DATE MAY 22, 2025).

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

PHILADELPHIA, PA / ACCESS NEWSWIRE / MARCH 31, 2025 / THE ABERDEEN U.S. CLOSED-END FUNDS (NYSE:ASGI, HQH, HQL, IFN, JEQ, THQ), (NYSE AMERICAN:IAF) (THE "FUNDS" OR INDIVIDUALLY THE "FUND"), TODAY ANNOUNCED THAT THE FUNDS PAID THE DISTRIBUTIONS NOTED IN THE TABLE BELOW ON MARCH 31, 2025, ON A PER SHARE BASIS TO ALL SHAREHOLDERS OF RECORD AS OF MARCH 25, 2025 (EX-DIVIDEND DATE MARCH 25, 2025). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF ABRDN HEALTHCARE INVESTORS (HQH), ABRDN LIFE SCIENCES INVESTORS (HQL), ABRDN AUSTRALIA EQUITY FUND, INC. (IAF), THE INDIA FUND INC. (IFN) AND ABRDN JAPAN EQUITY FUND, INC. (JEQ) WHICH PAID ON MARCH 31, 2025, TO ALL SHAREHOLDERS OF RECORD AS OF FEBRUARY 21, 2025 (EX-DIVIDEND DATE FEBRUARY 21, 2025).

ABERDEEN U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

PHILADELPHIA, PA / ACCESS NEWSWIRE / FEBRUARY 11, 2025 / THE FOLLOWING ABRDN U.S. CLOSED-END FUNDS (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, JEQ, THQ, THW)(NYSE AMERICAN:FAX, FCO, IAF, VFL), ANNOUNCED TODAY THAT THE CLOSED END FUNDS IN THE CHART DIRECTLY BELOW WILL PAY THE DISTRIBUTIONS INDICATED ON A PER SHARE BASIS ON FEBRUARY 28, 2025 TO ALL SHAREHOLDERS OF RECORD AS OF FEBRUARY 21, 2025 (EX-DIVIDEND DATE FEBRUARY 21, 2025). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF THE ABRDN HEALTHCARE INVESTORS (HQH), THE ABRDN LIFE SCIENCES INVESTORS (HQL), THE ABRDN AUSTRALIA EQUITY FUND, INC. (IAF), THE INDIA FUND, INC. (IFN) AND THE ABRDN JAPAN EQUITY FUND, INC. (JEQ) WHICH WILL PAY ON MARCH 31, 2025 TO ALL SHAREHOLDERS OF RECORD AS OF FEBRUARY 21, 2025 (EX-DIVIDEND DATE FEBRUARY 21, 2025).

ABRDN U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

PHILADELPHIA, PA / ACCESSWIRE / JANUARY 10, 2025 / THE ABRDN U.S. CLOSED-END FUNDS (NYSE:ASGI, HQH, HQL, IFN, JEQ, THQ)(NYSE AMERICAN:IAF) (THE "FUNDS" OR INDIVIDUALLY THE "FUND"), TODAY ANNOUNCED THAT THE FUNDS PAID THE DISTRIBUTIONS NOTED IN THE TABLE BELOW ON JANUARY 10, 2025, ON A PER SHARE BASIS TO ALL SHAREHOLDERS OF RECORD AS OF DECEMBER 30, 2024 (EX-DIVIDEND DATE DECEMBER 30, 2024). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF ABRDN HEALTHCARE INVESTORS (HQH), ABRDN LIFE SCIENCES INVESTORS (HQL), ABRDN AUSTRALIA EQUITY FUND, INC. (IAF), THE INDIA FUND INC. (IFN) AND ABRDN JAPAN EQUITY FUND, INC. (JEQ) WHICH PAID ON JANUARY 10, 2025, TO ALL SHAREHOLDERS OF RECORD AS OF NOVEMBER 21, 2024 (EX-DIVIDEND DATE NOVEMBER 21, 2024).

PHILADELPHIA, PA / ACCESSWIRE / NOVEMBER 11, 2024 / THE FOLLOWING ABRDN U.S. CLOSED-END FUNDS (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, JEQ, THQ, THW)(NYSE AMERICAN:FAX, FCO, IAF, VFL), ANNOUNCED TODAY THAT THE CLOSED END FUNDS IN THE CHART DIRECTLY BELOW WILL PAY THE DISTRIBUTIONS INDICATED ON A PER SHARE BASIS ON NOVEMBER 29, 2024 TO ALL SHAREHOLDERS OF RECORD AS OF NOVEMBER 21, 2024 (EX-DIVIDEND DATE NOVEMBER 21, 2024). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF THE ABRDN HEALTHCARE INVESTORS (HQH), THE ABRDN LIFE SCIENCES INVESTORS (HQL), THE ABRDN AUSTRALIA EQUITY FUND, INC. (IAF), THE INDIA FUND, INC. (IFN) AND THE ABRDN JAPAN EQUITY FUND, INC. (JEQ) WHICH WILL PAY ON JANUARY 10, 2025 TO ALL SHAREHOLDERS OF RECORD AS OF NOVEMBER 21, 2024 (EX-DIVIDEND DATE NOVEMBER 21, 2024).

PHILADELPHIA, PA / ACCESSWIRE / SEPTEMBER 30, 2024 / THE ABRDN U.S. CLOSED-END FUNDS (NYSE:ASGI, HQH, HQL, IFN, JEQ, THQ)(NYSE AMERICAN:IAF), (THE "FUNDS" OR INDIVIDUALLY THE "FUND"), TODAY ANNOUNCED THAT THE FUNDS PAID THE DISTRIBUTIONS NOTED IN THE TABLE BELOW ON SEPTEMBER 30, 2024, ON A PER SHARE BASIS TO ALL SHAREHOLDERS OF RECORD AS OF SEPTEMBER 23, 2024 (EX-DIVIDEND DATE SEPTEMBER 23, 2024). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF ABRDN HEALTHCARE INVESTORS (HQH), ABRDN LIFE SCIENCES INVESTORS (HQL), ABRDN AUSTRALIA EQUITY FUND, INC. (IAF), THE INDIA FUND INC. (IFN) AND ABRDN JAPAN EQUITY FUND, INC. (JEQ) WHICH PAID ON SEPTEMBER 30, 2024, TO ALL SHAREHOLDERS OF RECORD AS OF AUGUST 23, 2024 (EX-DIVIDEND DATE AUGUST 23, 2024), AND THE ABRDN GLOBAL INFRASTRUCTURE INCOME FUND (ASGI) WHICH PAID ON SEPTEMBER 30, 2024, TO ALL SHAREHOLDERS OF RECORD AS OF SEPTEMBER 20, 2024 (EX-DIVIDEND DATE SEPTEMBER 20, 2024).

PHILADELPHIA, PA / ACCESSWIRE / AUGUST 9, 2024 / THE FOLLOWING ABRDN U.S. CLOSED-END FUNDS (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE AMERICAN:FAX)(NYSE AMERICAN:FCO)(NYSE AMERICAN:IAF)(NYSE AMERICAN:VFL), ANNOUNCED TODAY THAT THE CLOSED END FUNDS IN THE CHART DIRECTLY BELOW WILL PAY THE DISTRIBUTIONS INDICATED ON A PER SHARE BASIS ON AUGUST 30, 2024 TO ALL SHAREHOLDERS OF RECORD AS OF AUGUST 23, 2024 (EX-DIVIDEND DATE AUGUST 23, 2024). THESE DATES APPLY TO THE FUNDS LISTED BELOW WITH THE EXCEPTION OF THE ABRDN HEALTHCARE INVESTORS (HQH), THE ABRDN LIFE SCIENCES INVESTORS (HQL), THE ABRDN AUSTRALIA EQUITY FUND, INC. (IAF), THE INDIA FUND, INC. (IFN) AND THE ABRDN JAPAN EQUITY FUND, INC. (JEQ) WHICH WILL PAY ON SEPTEMBER 30, 2024, TO ALL SHAREHOLDERS OF RECORD AS OF AUGUST 23, 2024 (EX-DIVIDEND DATE AUGUST 23, 2024).

PHILADELPHIA, PA / ACCESSWIRE / JULY 5, 2024 / THE INDIA FUND, INC. ("IFN") (THE "FUND"), TODAY ANNOUNCED THAT THE FUND PAID THE DISTRIBUTION NOTED IN THE TABLE BELOW ON JULY 5, 2024, ON A PER SHARE BASIS TO ALL SHAREHOLDERS OF RECORD AS OF MAY 30, 2024 (EX-DIVIDEND DATE MAY 30, 2024). TICKER EXCHANGE FUND AMOUNT IFN NYSE THE INDIA FUND, INC. $0.4500 THE FUND HAS ADOPTED A DISTRIBUTION POLICY TO PROVIDE INVESTORS WITH A STABLE DISTRIBUTION OUT OF CURRENT INCOME, SUPPLEMENTED BY REALIZED CAPITAL GAINS AND, TO THE EXTENT NECESSARY, PAID-IN CAPITAL.

THE INDIA FUND INC. ANNOUNCES PAYMENT OF DISTRIBUTION

PHILADELPHIA, PA / ACCESSWIRE / MAY 20, 2024 / THE INDIA FUND, INC. (NYSE:IFN), ANNOUNCED TODAY THAT IT WILL PAY $0.45 ON A PER SHARE BASIS ON JULY 5, 2024 TO ALL SHAREHOLDERS OF RECORD AS OF MAY 30, 2024 (EX-DIVIDEND DATE MAY 30, 2024). FOR THE INDIA FUND, INC. ("IFN"), THIS STOCK DISTRIBUTION WILL AUTOMATICALLY BE PAID IN NEWLY ISSUED SHARES OF THE FUND UNLESS OTHERWISE INSTRUCTED BY THE SHAREHOLDER.TICKEREXCHANGEFUNDAMOUNTIFNNYSETHE INDIA FUND, INC.$ 0.45AT THE END OF EACH CALENDAR YEAR, A FORM 1099-DIV WILL BE SENT TO SHAREHOLDERS, WHICH WILL STATE THE AMOUNT AND COMPOSITION OF THE FUND'S DISTRIBUTIONS AND PROVIDE INFORMATION WITH RESPECT TO THEIR APPROPRIATE TAX TREATMENT FOR THE PRIOR CALENDAR YEAR. YOU SHOULD NOT DRAW ANY CONCLUSIONS ABOUT THE FUND'S INVESTMENT PERFORMANCE FROM THE AMOUNT OF THE DISTRIBUTIONS.FOR THE INDIA FUND, INC. ("IFN"), THIS STOCK DISTRIBUTION WILL AUTOMATICALLY BE PAID IN NEWLY ISSUED SHARES OF THE FUND UNLESS OTHERWISE INSTRUCTED BY THE SHAREHOLDER. SHARES OF COMMON STOCK WILL BE ISSUED AT THE LOWER OF THE NET ASSET VALUE ("NAV") PER SHARE OR THE MARKET PRICE PER SHARE WITH A FLOOR FOR THE NAV OF NOT LESS THAN 95% OF THE MARKET PRICE. THE VALUATION DATE FOR THIS STOCK DISTRIBUTION IS JUNE 21, 2024. FRACTIONAL SHARES WILL GENERALLY BE SETTLED IN CASH, EXCEPT FOR REGISTERED SHAREHOLDERS WITH BOOK ENTRY ACCOUNTS AT COMPUTERSHARE INVESTOR SERVICES WHO WILL HAVE WHOLE AND FRACTIONAL SHARES ADDED TO THEIR ACCOUNT.SHAREHOLDERS MAY REQUEST TO BE PAID THEIR QUARTERLY DISTRIBUTIONS IN CASH INSTEAD OF SHARES OF COMMON STOCK BY PROVIDING ADVANCE NOTICE TO THE BANK, BROKERAGE OR NOMINEE WHO HOLDS THEIR SHARES IF THE SHARES ARE IN "STREET NAME," OR BY FILLING OUT IN ADVANCE AN ELECTION CARD RECEIVED FROM COMPUTERSHARE INVESTOR SERVICES IF THE SHARES ARE IN REGISTERED FORM. TO RECEIVE THE QUARTERLY DISTRIBUTION PAYABLE IN JULY 2024 IN CASH INSTEAD OF SHARES OF COMMON STOCK, THE BANK, BROKERAGE OR NOMINEE WHO HOLDS THE SHARES MUST ADVISE THE DEPOSITO

THE INDIA FUND, INC. ANNOUNCES DISTRIBUTION PAYMENT DETAILS

THE SON-1010 STUDIES HAVE TOGETHER ENROLLED 61 SUBJECTS, TO DATE, AS DOSE ESCALATION CONTINUES IN SB101 AND SB221 AT HIGHER LEVELSPATIENTS HAVE RECEIVED UP TO 25 CYCLES OF SON-1010 AS MONOTHERAPY AND 10 CYCLES OF SON-1010 WITH ATEZOLIZUMAB (TECENTRIQ) WITHOUT DOSE-LIMITING TOXICITY AT ANY DOSE LEVELCYTOKINE DATA REVEALS ABOUT 10-FOLD EXTENDED HALF-LIFE FOR SON-1010 COMPARED WITH RHIL-12 THAT INDUCES PROLONGED AND CONTROLLED IFN RESPONSES, WITH NO EVIDENCE OF CYTOKINE RELEASE SYNDROME AT ANY DOSECLINICAL BENEFIT WAS SEEN AT FOUR MONTHS POST-INITIATION OF DOSING IN 35% OF EVALUABLE PATIENTS (8/23) WITH ADVANCED SOLID TUMORS PRINCETON, NJ / ACCESSWIRE / MAY 20, 2024 / SONNET BIOTHERAPEUTICS HOLDINGS, INC. (NASDAQ:SONN) (THE "COMPANY" OR "SONNET"), A CLINICAL-STAGE COMPANY DEVELOPING TARGETED IMMUNOTHERAPEUTIC DRUGS, ANNOUNCED TODAY THAT THE SAFETY OF SON-1010 DOSING HAS BEEN FORMALLY REVIEWED IN BOTH OF THE CURRENT PHASE 1 CLINICAL TRIALS AND THE COMPANY IS NOW INCREASING THE TARGET DOSE OF SON-1010 DURING DOSE ESCALATION. SON-1010 IS A PROPRIETARY VERSION OF RECOMBINANT HUMAN INTERLEUKIN-12 (RHIL-12), CONFIGURED USING SONNET'S FULLY HUMAN ALBUMIN BINDING (FHAB) PLATFORM, WHICH EXTENDS THE HALF-LIFE AND ACTIVITY OF THE IL-12 COMPONENT DUE TO BINDING NATIVE ALBUMIN IN THE SERUM AND TARGETS THE TUMOR MICROENVIRONMENT (TME) BY STRONGLY BINDING GP60 AND SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC). SB101 IS A PHASE 1 MULTIPLE-ASCENDING DOSE (MAD) TRIAL IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS (NCT05352750) THAT COMMENCED IN Q2 2022 AND IS CURRENTLY ENROLLING THE SIXTH DOSE COHORT. SB221 IS A PHASE 1B/2A DOSE-ESCALATION AND PROOF-OF-CONCEPT STUDY OF THE COMBINATION OF SON-1010 WITH ATEZOLIZUMAB (IN COLLABORATION WITH GENENTECH, A MEMBER OF THE ROCHE GROUP), IN A STUDY FOCUSED ON PLATINUM-RESISTANT OVARIAN CANCER (PROC) (NCT05756907) THAT STARTED IN Q4 2023, NOW ENROLLING THE FOURTH DOSE COHORT. IN ADDITION, SON-1010 WAS STUDIED IN SB102, WHICH WAS A PHASE 1 SING

SONNET BIOTHERAPEUTICS ANNOUNCES UPDATED CLINICAL DATA FOR SON-1010 AS MONOTHERAPY OR COMBINED WITH AN ANTI-PD-L1, ALONG WITH AN INCREASE IN THE DOSE-ESCALATION TARGET

The India Fund, Inc.

IFN

Price

Financials Overview

Financial Reports

No items found.

Press Releases

The India Fund, Inc.

IFN.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

IFN